FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082810 [Registered on: 19/03/2025] Trial Registered Prospectively
Last Modified On: 08/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   A Study on How Dark Spots are Reduced When You Use Kumkumadi Oil 
Scientific Title of Study   Exploring the Physiological Effects of Topical Kumkumadi Taila on Cutaneous Microcirculation and Melanogenesis in Hyperpigmentation: A Dermatoscopic Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Smita Chatrabhuji 
Designation  Post Graduate Scholar 
Affiliation  Parul Institute of Ayurved 
Address  Department of Kriya Sharir, Parul Institute of Ayurved, Parul University, At Post Limda, Taluka Waghodia, District Vadodara, Gujarat. Pincode - 391760

Vadodara
GUJARAT
391760
India 
Phone  6352644564  
Fax    
Email  dr.smitachatrabhuji@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vaidehi Raole 
Designation  Professor and HOD 
Affiliation  Parul Institute of Ayurved 
Address  Department of Kriya Sharir, Parul Institute of Ayurved, Parul University, At Post Limda, Taluka Waghodia, District Vadodara, Gujarat. Pincode - 391760

Vadodara
GUJARAT
391760
India 
Phone  9824284371  
Fax    
Email  vaidehi.raole@paruluniversity.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Vaidehi Raole 
Designation  Professor and HOD 
Affiliation  Parul Institute of Ayurved 
Address  Department of Kriya Sharir, Parul Institute of Ayurved, Parul University, At Post Limda, Taluka Waghodia, District Vadodara, Gujarat. Pincode - 391760

Vadodara
GUJARAT
391760
India 
Phone  9824284371  
Fax    
Email  vaidehi.raole@paruluniversity.ac.in  
 
Source of Monetary or Material Support  
Parul Institute of Ayurved and Parul Ayurved Hospital 
 
Primary Sponsor  
Name  Parul Institute of Ayurved 
Address  Parul Institute of Ayurved, Parul University, At Post Limda, Taluka Waghodia, District Vadodara, Gujarat. Pincode - 391760 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
Vasu Healthcare Pvt Ltd  967/4, G.I.D.C., Makarpura, Vadodara - 390010, Gujarat (India) Contact Person: Dr. Hardik Soni 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Smita Chatrabhuji  Parul Institute of Ayurved and Parul Ayurved Hospital  Department of Kriya Sharir, Parul Institute of Ayurved, Parul University, At Post Limda, Taluka Waghodia, District Vadodara, Gujarat. Pincode - 391760
Vadodara
GUJARAT 
6352644564

dr.smitachatrabhuji@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Parul Institute of Ayurved - Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L814||Other melanin hyperpigmentation. Ayurveda Condition: VYANGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Kumkumadi Taila, Reference: Bhaishajya Ratnavali, Route: Topical, Dosage Form: Taila, Dose: 1(NA), Frequency: hs, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Skin Type : Fitzpatrick skin types III-VI (to ensure relevance to individuals prone to hyperpigmentation).

Hyperpigmentation Diagnosis: Clinically diagnosed with one of the following types of hyperpigmentation: Melasma, Post-inflammatory hyperpigmentation, Solar lentigines (sun spots) 
 
ExclusionCriteria 
Details  Pregnancy or Lactation:
Pregnant or breastfeeding women (due to potential hormonal influences on pigmentation).

Active Skin Infections:
Presence of active skin infections or inflammatory conditions
(e.g., eczema, psoriasis) at the study site (to avoid confounding the assessment of hyperpigmentation). 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Changes in cutaneous microcirculation parameters (vessel density, morphology) within and around hyperpigmented lesions assessed via dermatoscopy at baseline, 8 weeks, and 12 weeks.

Alterations in melanin distribution patterns within hyperpigmented lesions as observed through dermatoscopy at baseline, 8 weeks, and 12 weeks. 
Baseline, 8 weeks, and 12 weeks. 
 
Secondary Outcome  
Outcome  TimePoints 
Subjective assessment of hyperpigmentation improvement using the Melasma Area and Severity Index (MASI) questionnaire at baseline, 8 weeks, and 12 weeks  Baseline, 8 weeks, and 12 weeks. 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   09/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This single-center, prospective, post-marketing surveillance study aims to investigate the physiological effects of topically applied Kumkumadi Taila, a classical Ayurvedic medicine with a long history of use for hyperpigmentation.

The study will enroll 200 participants with clinically diagnosed hyperpigmentation (melasma, post-inflammatory hyperpigmentation, or solar lentigines).

Participants will apply Kumkumadi Taila topically for 8 weeks, with follow-up assessments at 8 and 12 weeks.

  • The primary outcomes are changes in cutaneous microcirculation (vessel density and morphology) and melanin distribution patterns, as assessed through non-invasive dermatoscopy.
  • Secondary outcomes include subjective improvements in hyperpigmentation, as measured by the Melasma Area and Severity Index (MASI).

The study has been approved by the Institutional Ethics Committee (IEC) of Parul Institute of Ayurved, Parul University, Vadodara, Gujarat.

This research will contribute novel insights into the physiological basis of Kumkumadi Taila’s traditional use in managing hyperpigmentation and potentially inform future applications.
 
Close